Skip to main content

Association between time to surgery and hospital mortality in patients with community-acquired limb necrotizing fasciitis: an 11-year multicenter retrospective cohort analysis

Abstract

Background

Necrotizing fasciitis (NF) is a rare but potentially life-threatening soft tissue infection. The objective of this study was to assess the association between timely surgery within 6 h and hospital mortality in patients with limb NF, and to describe the trends in patients with NF, time to surgery and standardized mortality ratio (SMR) over 11 years.

Methods

This was a multicenter, retrospective cohort study of all intensive care unit patients who had emergency surgery within 24 h of hospitalization for limb NF between April 1, 2008 and March 31, 2019 in Hong Kong. Timely surgery was defined as the first surgical treatment within 6 h of initial hospitalization. Appropriate antibiotics were achieved if the patient was given antibiotic(s) for all documented pathogens prior to or on day of culture results. The primary outcome was hospital mortality.

Results

There were 495 patients (median age 62 years, 349 (70.5%) males) with limb NF treated by surgery within 24 h of hospitalization over the 11 years. Appropriate antibiotic(s) were used in 392 (79.2%) patients. There were 181 (36.5%) deaths. Timely surgery was not associated with hospital mortality (Relative Risk 0.89, 95% CI: 0.73 to 1.07) but admission year, advanced age, higher severity of illness, comorbidities, renal replacement therapy, vasopressor use, and type of surgery were significant predictors in the multivariable model. There was an upward trend in NF diagnosis (1.9 cases/year, 95% CI: 0.7 to 3.1; P < 0.01; R2 = 0.60) but there was no downward trend in median time to surgery (-0.2 h/year, 95% CI: -0.4 to 0.1; P = 0.16) or SMR (-0.02/year, 95% CI: -0.06 to 0.01; P = 0.22; R2 = 0.16).

Conclusions

Among patients operated within 24 h, very early surgery within 6–12 h was not associated with survival. Increasing limb NF cases were reported each year but mortality remained high despite a high rate of appropriate antibiotic use and timely surgical intervention.

Peer Review reports

Introduction

Necrotizing fasciitis (NF) is a rare but life-threatening severe soft tissue infection involving the skin, subcutaneous tissue, and superficial fascia (Fig. 1) [1, 2]. The annual incidence of NF ranges from 1.7 cases per 100,000 population in New Zealand [3] to 11.6 cases per 100,000 in Taiwan [4]. NF is categorized into polymicrobial type I and monomicrobial type II infections [1]. Type I NF is usually caused by a combination of aerobic and anaerobic organisms in patients with comorbidities [5]. In contrast, Type 2 NF affects healthy patients and is often due to group A Streptococcus (GAS) or Staphylococcus aureus [6]. Environmental factors also determine causative pathogens as Methicillin-resistant Staphylococcus aureus (MRSA) is a substantial cause of NF in communities with a high prevalence of MRSA [7]. In tropical and coastal regions, Vibrio and Aeromonas species are common causes of NF due to the temperate climate and seawater exposure [8].

Fig. 1
figure 1

Leg with necrotizing fasciitis

A recent meta-analysis found that the mortality of NF remains high at 21% and survival has not improved over the last 20 years [9]. This may be partly due to the difficulty in diagnosis [10]. Presentation is highly variable, ranging from disproportionate pain relative to skin erythema, blisters, or gangrenous changes of skin [10]. Once the diagnosis is suspected, the key management priorities include prompt surgery with aggressive debridement of necrotic tissue for histological diagnosis and source control, as well as timely administration of appropriate broad-spectrum antibiotics [11]. Additional clindamycin is sometimes advocated for synergistic toxin suppression for GAS NF [12].

Conclusive high-quality evidence on the optimal medical and surgical interventions for NF are lacking [13]. Factors associated with increased mortality in NF include high severity of illness by APACHE score [14], presence of bacteraemia [15], hypotension [16], advanced age [17] and comorbidities [18]. More importantly, reducing the time to surgical treatment within 6 to 12 h may be a modifiable risk factor to improve survival [9, 11, 19,20,21]. However, many of these studies did not evaluate whether appropriate antibiotics were given [9, 20,21,22]. To address this knowledge gap, the primary objective of this study was to assess the association between time to surgery within 6 h and hospital mortality in critically ill patients with community-acquired limb NF. The secondary objective was to describe the trend in limb NF cases, time to surgery and standardized mortality ratio (SMR) between 2008 and 2018. We hypothesised that surgical treatment within 6 h would be an independent factor associated with improved survival after adjustment for other covariates. Furthermore, time to surgery has decreased and standardized mortality ratio has improved over the last decade.

Methods

Study design and population

This was a multicenter, retrospective cohort study conducted at 15 public hospitals in Hong Kong. This study was approved by The Joint Chinese University of Hong Kong – New Territories East Cluster Clinical Research Ethics Committee (2020.078), The Hong Kong East Cluster Research Ethics Committee (HKECREC-2020-030), The Institutional Review Board of The University of Hong Kong/Hospital Authority Hong Kong West Cluster (UW20-288), The Research Ethics Committee of Kowloon Central/Kowloon East (KC/KE-20-007/ER-1), The Kowloon West Cluster Research Ethics Committee (KW/EX-20-077(148-01)) and New Territories West Cluster Research Ethics Committee (NTWC/REC/20,058). Each individual ethics committee granted waiver of informed consent for this study. The STROBE guideline was used to ensure proper reporting of methods, results, and discussion [23].

All adult intensive care unit (ICU) patients with a diagnosis of NF who had emergency surgical treatment between 1 April 2008 and 31 March 2019 (inclusive) were included. For patients with recurrent ICU admissions during the same hospitalization, only data from their first ICU admissions was used. Exclusion criteria included: necrotizing fasciitis primarily involving sites other than the limbs (head and neck, chest, back, abdomen, perineum or groin areas) and missing hospital discharge status. Patients who only had emergency surgery after 24 h of hospital admission were excluded. The rationale was to focus on patients who presented with community acquired NF.

Data collection and variable definitions

Patients fulfilling the inclusion and exclusion criteria were identified using Clinical Data Analysis and Reporting System (CDARS), an electronic health database of the Hospital Authority in Hong Kong. CDARS contains inpatient and outpatient clinical information including clinical notes, laboratory results, microbiological results, operation records, diagnosis, procedures of inpatient, outpatient and Accident and Emergency Department care. We identified patients with a diagnosis of NF by hospital discharge International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code of Necrotizing fasciitis (728.86:0). The Charlson Comorbidity Index Score [24] was calculated using all inpatient and outpatient ICD-9-CM codes collected for each patient within 10 years before hospital admission [18]. We collected the Acute Physiology and Chronic Health Evaluation (APACHE) IV score [25], use of organ function supportive therapies including vasopressors, mechanical ventilation and renal replacement therapy (RRT), antibiotics use, and microbiology results from cultures of body fluids, wound swabs or surgical specimens.

Time to surgery was defined as the time interval between hospital admission and the start of emergency surgery. Timely surgical treatment was defined as within six hours (or within 12 h in the sensitivity analysis) between the time of initial hospital admission and emergency surgery. Surgery within these thresholds were recently shown in a meta-analysis to be associated with improved survival [9]. The primary outcome was hospital mortality which is defined as all-cause mortality at time of hospital discharge.

Type of surgery was classified into three categories:

(1) debridement only, in which only surgical debridement or other equivalent procedures were performed throughout the entire hospital admission;

(2) amputation first, in which amputation was performed within the first surgical session documented during the hospital admission; and (3) debridement followed by amputation, in which only debridement or other equivalent procedures were performed during the first surgical session, followed by amputation of any affected limb(s) in subsequent sessions.

Microbiological results were classified into monomicrobial, polymicrobial or culture-negative infections, according to the culture results of body fluids, wound swabs or surgical specimens obtained within 48 h of hospital admission. Appropriate antibiotics were achieved if the patient was given antibiotic(s) for all documented pathogens prior to or on day of culture results. Operation booking category was defined as the priority category of the emergency surgery which was either urgent (within 1 h) or semi-urgent (within 24 h) at time of surgery booking. This was used to provide further stratification of severity prior to surgery as patients with higher severity of disease are usually prioritized urgently for surgery.

Data analysis

Demographics and other baseline characteristics were expressed as descriptive statistics. Continuous data were reported as mean and standard deviation (SD) or median and interquartile range (IQR) as appropriate after checking visually and using Shapiro-Wilk’s test for normality. Frequency (%) was reported for categorical variables. The APACHE IV adjusted standardized mortality ratio was calculated by the number of deaths divided by the expected number of deaths during the 11 years.

Complete case analysis was used. We performed Chi-square tests to examine the association between categorical variables and mortality. Mann-Whitney U tests were used to assess the differences in the duration of ICU and hospital stays between time-to-surgery groups. We adjusted for age groups, APACHE IV groups, Charlson Comorbidity Index Score, type of infection, presence of bacteraemia, use of appropriate antibiotics, mechanical ventilation, RRT, vasopressor, type of surgery and operation booking category as confounders and year of admission in a multivariable model after constructing a directed acyclic graph (DAG) [26] using DAGitty software (http://www.dagitty.net/). In the DAG model (Supplemental Fig. 1), we were interested in the direct effect of time to surgery on the risk of hospital mortality. A modified Poisson regression model with a robust error variance [27] was used to assess the association between timely surgery (< 6 h) and hospital mortality. The relative risk (RR) of hospital mortality with the associated 95% confidence interval (95% CI) were reported. The model discrimination performance was assessed using an area under the receiver operating characteristic curve (AUROC) and a calibration belt was drawn to visually compare the observed versus expected risk of hospital mortality [28]. A sensitivity analysis was performed to assess the association between timely surgery within 12 h and hospital mortality. We used a quantile regression to estimate the trend in median time to surgery over 11 years and a linear regression to assess the hospital mortality trend over this study period. The statistical analyses were performed using Stata version 18.0 (StataCorp, College Station, TX). The level of significance was set at p < 0.05.

Results

During the 11-year study period between 1 April 2008 and 31 March 2019, there were 133,858 admissions to the 15 general ICUs in Hong Kong. Of these 133,858 ICU admissions, 869 critically ill patients had NF and 700 received surgical treatment (Fig. 2). Among these 700 NF cases, 495 had surgical treatment within 24 h of hospitalization and were included in the final study cohort (Fig. 2, Supplemental Fig. 2). The number of surgeries performed within 6 h, 6 to 12 h and 12 to 24 h were 212 (42.8%), 153 (30.9%) and 130 (26.3%) respectively.

Fig. 2
figure 2

Patient flow diagram

The patient demographics and clinical characteristics are shown in Table 1 and Supplemental Table 1. Most patients (71%) had monomicrobial infections. The most common organisms (Table 2) for patients with monomicrobial infections were Streptococcus pyogenes (34%) and Vibrio species (22.4%). Amongst the whole cohort, the mortality rates for patients with Streptococcus pyogenes and Vibrio species were 24.4% (30/123) and 39.1% (34/87), respectively. Quinolones (67%), penicillins (62%) and clindamycin (56%) were the most frequently used antimicrobial agents (Table 3). At least 12% of patients were not given appropriate antibiotics (Table 1, Supplemental Table 2). The antimicrobial resistance rates for various organisms are shown in Supplemental Table 3. Among the 170 patients with bacteraemia, a total of 91 (53.5%) patients had the same pathogen isolated from wounds.

Table 1 Patient demographics and clinical characteristics
Table 2 Type of microorganisms
Table 3 Antimicrobial use on Day 1 of hospitalization

Of the 495 patients, 212 (42.8%) had surgery within six hours. Timely surgery within six hours of initial hospital admission was not associated with hospital mortality in both unadjusted (RR 0.86, 95% CI: 0.63 to 1.17) and adjusted analysis (RR 0.89, 95% CI: 0.73 to 1.07) (Table 4). In the multivariable analysis, the significant factors associated with hospital mortality were the year of admission, higher age groups, higher severity of illness groups, comorbidity score, RRT, vasopressor use and type of surgery (Table 4). The model had excellent discrimination (AUROC 0.92, 95% CI: 0.90 to 0.95) and good calibration performance (p = 0.32; Supplemental Fig. 3). Three hundred and sixty-three (73.3%) patients had surgery within 12 h. In the sensitivity multivariable analysis, there was no association between timely surgery within 12 h of initial hospital admission and hospital mortality (Supplemental Table 4); however, the same factors in Table 4 were associated with hospital mortality. The sensitivity analysis model also had excellent discrimination (AUROC 0.92, 95% CI: 0.90 to 0.95) and good calibration performance (p = 0.46; Supplemental Fig. 4).

Table 4 Association between time to surgery (< 6 h) and risk of hospital mortality (unadjusted and adjusted relative risk) after taking hospital intensive care unit clustering effect into account in the model

In the unadjusted analyses, there was an increasing trend in the annual rate of NF cases over time (1.9 cases/year, 95% CI: 0.7 to 3.1; p < 0.01; R2 = 0.60; Fig. 3A). Although the median (IQR) time to surgery (hours) decreased from 8.1 (95% CI: 6.6 to 9.6) in 2008 to 6.4 (95% CI: 5.1 to 7.7) in 2018, the downward trend over time was not significant (-0.2 h/year, 95% CI: -0.4 to 0.1; p = 0.16; Fig. 3B). The ICU mortality was 27.1% (95% CI: 23.2–31.2%). The hospital mortality was 36.6% (95% CI: 32.3–41.0%). The APACHE IV adjusted SMR decreased from 0.81 (95% CI: 0.61 to 1.02) in 2008 to 0.61 (95% CI: 0.40 to 0.81) in 2018 although the downward trend over time was not significant (-0.02/year, 95% CI: -0.06 to 0.01; p = 0.22; R2 = 0.16; Fig. 3C).

Fig. 3
figure 3

Trend over April 2008 to March 2019. (A) number of necrotizing fasciitis (NF), (B) median time (hours) to surgery and (C) severity of illness adjusted standardized mortality ratio (SMR)

Patients treated with surgery within six hours of initial hospital admission were not associated with a shorter length of stay in ICU (days) compared to those with a delayed surgery (median (IQR) 4.2 (2.5 to 7.8) versus 4.5 (2.4 to 8.8) days; p = 0.73). Likewise, surgery within six hours was not associated with a shorter duration of hospital stay (days) than those with a delayed surgery (median (IQR) 26.9 (10.7 to 46.6) versus 27.2 (11.0 to 46.8) days; p = 0.87).

Discussion

The objective of this study was to use a large retrospective cohort of patients with community acquired limb NF to assess the association between time to surgery within 6 h and hospital mortality. We found that time to surgery within six hours (or 12 h) of hospital admission was not associated with hospital mortality after adjusting for multiple confounders. The overall APACHE IV adjusted SMR is low for critically ill patients with limb NF in Hong Kong, but there was no significant decline in either median time to surgery or SMR over the 2008 to 2018 period. Overall, there were approximately two additional cases of limb NF per year occurring over the study period. Streptococcus pyogenes was the most prevalent microorganism isolated (34%), whilst Vibrio species (22%) was also common.

Our baseline demographics and comorbidity profile were similar to previous studies [11, 17, 18]. In the current study, the median age was 62 years, with 71% being males; diabetes and cardiovascular disease (myocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease) remained the most frequently reported comorbidities. Mild chronic liver disease was also prevalent (15%) which may be attributed to the high rate of chronic hepatitis carriage in our population. Patients with uncontrolled diabetes were at a higher risk of mortality than those with controlled diabetes [29]; however, the current dataset did not include the HbA1c level to examine this aspect. Nevertheless, it is important to highlight the SMR of limb NF patients in Hong Kong is low. Although this study did not demonstrate statistically significant improvement of SMR over time, it has been shown that the trend is consistent with the decreasing SMR of all ICU patients in Hong Kong during the same period [30]. Although the overall 37% hospital mortality rate reported is higher than average mortality rate of 20% reported in a recent meta-analysis which included all severity of patients [9], it is comparable to cohorts of critically ill patients with NF from France [31] and Netherlands [32].

Consistent with previous studies [2, 11], S. pyogenes was the most common microorganism isolated (34%); other beta-hemolytic streptococci, such as group C or G Streptococcus (12%), are also emerging [33]. Of note, our high rate of clindamycin resistance is within the reported clindamycin resistance rate ranging from 15% in the USA [34] to 96% in China [35]. Our cohort showed that Vibrio species (22%) was the second most common causative organism, reinforcing the need to consider empirical quinolone coverage during presentation. A systematic review showed that more than 95% of the Vibrio vulnificus NF cases occurred in the subtropical western Pacific and Atlantic coastal regions in the Northern Hemisphere [8]. However, climate change has been suggested as a cause of rising Vibrio infections in North America [36]. Staphylococcus aureus, both sensitive and resistant strains, were also quite prevalent in our cohort, consistent with a previous Taiwanese study [37].

Many studies have explored the predictors of adverse outcomes with this potentially fatal disease. Although there is no consensus for specific predictors of mortality so far, commonly agreed factors include advanced age, high severity of illness, delayed presentation and delayed intervention, and positive blood culture [38, 39]. Our study also showed that admission year, advanced age, a higher APACHE IV score and comorbidities were independently associated with a higher risk of hospital mortality.

This study did not show a difference in the risk of hospital mortality between the time to first surgery and appropriateness of antibiotic use groups in the multivariable model. While it may seem common sense that targeting early antimicrobial administration is essential, conclusive high-quality evidence on the exact time threshold for antimicrobial [40] administration in sepsis remains unsettled [41]. A possible reason that this was not shown in this study was because we considered a more conservative approach by classifying unknown with inappropriate initial antibiotics in the multivariate analysis. Similarly, although early surgery and source control is recommended by guidelines, there is conflicting evidence from individual studies on whether early surgery can improve survival in NF [21, 42]. There are a few reasons why our study could not demonstrate benefits of early surgery. First, for patients with sepsis or septic shock, supportive care and resuscitation play a significant role in survival apart from treatment of underlying infection. This is demonstrated by the large adjusted RR of vasopressor therapy, dialysis and APACHE IV score in the multivariable model. Second, even though we used operation booking category as a surrogate to account for preoperative severity, residual bias from other preoperative characteristics may have confounded the effects of surgery time on outcomes. Third, we excluded patients who had surgery only after 24 h of hospital admission. This may have made it harder to demonstrate the benefits of very early surgery (< 6 h) as all patients received surgery within same day of hospital admission [19].

Nonetheless, Nawijn and colleagues (2020) showed a significant reduction in mortality risk associated with surgery within 6 and 12 h after presentation compared to delayed surgery in a systematic review of observational studies [9]. In a post-hoc analysis, the addition of our study data to Nawijn et al.’s meta-analysis of 10 studies (n = 512) of surgery within 6 h [9] still gave rise to a significant mortality reduction (RR 0.77, 95% CI: 0.64 to 0.93, I2 = 0%; Supplemental Fig. 5) despite a large weighting (60%) from the current study in the random-effects meta-analysis. Similarly, the addition of our study data to the meta-analysis of 15 studies (n = 669) of surgery within 12 h [9] leads to a significant mortality reduction (RR 0.70, 95% CI: 0.59 to 0.84, I2 = 0%; Supplemental Fig. 6) despite a large weighting (51%) from the current study in the random-effects meta-analysis. Overall, the totality of evidence suggests that surgery within 12 h is associated with a lower risk of hospital mortality. Taken together, our data suggests clinical care could be optimized for at least 12% of patients who are not receiving appropriate empirical antimicrobials and 57% or 27% of patients who are not receiving surgery within 6–12 h of hospital admission.

Our study has several strengths. It is one of the largest retrospective longitudinal cohort studies performed on necrotizing soft tissue infections, involving 15 general ICUs across the whole city of Hong Kong, spanning over 11 years. We standardized the comorbidity categories using the Charlson Comorbidity Index [24]. Our study evaluated the sensitivity patterns of isolated organisms in contrast to many previous studies [9, 20,21,22] that rarely assessed this. We also examined two key aspects of management — type of surgeries performed and appropriateness of antibiotics used.

On the other hand, there are several limitations. First, as the study lacked information regarding the timing of symptom onset and presentation, the impact of delayed presentation on outcome is uncertain as we only assessed the significance of time interval between hospital admission to surgery on survival. Second, we did not examine the diagnostic process, which is notoriously difficult due to the wide spectrum of presentations. A commonly used predictive scoring system, such as the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) [43], has not been comprehensively externally validated and calibrated. A recent diagnostic test accuracy systematic review of the performance of LRINEC for identifying NF in the extremities showed only fair accuracy [44]. Further studies are needed to validate a robust predictive model for the timely diagnosis of NF, which is crucial in the initial management of such patients. Third, as treatment was not protocolized, the diversity of clinical practice across both different hospitals and time may imposed substantial bias and confounding in this long retrospective multicenter study. Fourth, all-cause mortality at hospital discharge was used and no data on limitation or withdrawal of life sustaining therapy was available.

Conclusion

Our large retrospective cohort study over 11 years demonstrated a high mortality rate among patients with community-acquired limb NF. Monomicrobial infection constituted most cases, with S. pyogenes being the most common causative organism, although marine-related bacteria are also prevalent in our region. Among patients operated within 24 h, very early surgery within 6–12 h was not associated with survival. The admission year, advanced age, high APACHE IV score, comorbidities, RRT, vasopressor use, and type of surgery were significant predictors of hospital mortality.

Data availability

All data generated or analysed during this study are included in this published article [and its supplementary information files].

Abbreviations

APACHE IV:

Acute Physiology and Chronic Health Evaluation IV

AUROC:

area under the receiver operating characteristic curve

CDARS:

Clinical Data Analysis and Reporting System

CI:

confidence interval

DAG:

directed acyclic graph

GAS:

group A Streptococcus

ICD-9-CM:

International Classification of Diseases, Ninth Revision, Clinical Modification

ICU:

intensive care unit

MRSA:

Methicillin-resistant Staphylococcus aureus

NF:

Necrotizing fasciitis

RR:

relative risk

RRT:

renal replacement therapy

SMR:

standardized mortality ratio

References

  1. Cheung JP, Fung B, Tang WM, Ip WY. A review of necrotising fasciitis in the extremities. Hong Kong Med J. 2009;15:44–52.

    PubMed  Google Scholar 

  2. Khamnuan P, Chongruksut W, Jearwattanakanok K, Patumanond J, Tantraworasin A. Necrotizing fasciitis: epidemiology and clinical predictors for amputation. Int J Gen Med. 2015;8:195–202.

    PubMed  PubMed Central  Google Scholar 

  3. Das DK, Baker MG, Venugopal K. Increasing incidence of necrotizing fasciitis in New Zealand: a nationwide study over the period 1990 to 2006. J Infect. 2011;63:429–33.

    Article  PubMed  Google Scholar 

  4. Chuang KL, Liang FW, Shieh SJ, Lu TH. The incidence of necrotizing fasciitis in Taiwan: a nationwide population-based study. Ann Plast Surg. 2018;80(2S Suppl 1):S75–8.

    Article  CAS  PubMed  Google Scholar 

  5. Puvanendran R, Huey JC, Pasupathy S. Necrotizing fasciitis. Can Fam Physician. 2009;55:981–7.

    PubMed  PubMed Central  Google Scholar 

  6. Sarani B, Strong M, Pascual J, Schwab CW. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg. 2009;208:279–88.

    Article  PubMed  Google Scholar 

  7. Young LM, Price CS. Community-acquired methicillin-resistant Staphylococcus aureus emerging as an important cause of necrotizing fasciitis. Surg Infect (Larchmt). 2008;9:469–74.

    Article  PubMed  Google Scholar 

  8. Huang KC, Weng HH, Yang TY, Chang TS, Huang TW, Lee MS. Distribution of fatal Vibrio vulnificus necrotizing skin and soft-tissue infections: a systematic review and meta-analysis. Med (Baltim). 2016;95:e2627.

    Article  Google Scholar 

  9. Nawijn F, Smeeing DPJ, Houwert RM, Leenen LPH, Hietbrink F. Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis. World J Emerg Surg. 2020;15:4.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Goh T, Goh LG, Ang CH, Wong CH. Early diagnosis of necrotizing fasciitis. Br J Surg. 2014;101:e119–25.

    Article  CAS  PubMed  Google Scholar 

  11. Peetermans M, de Prost N, Eckmann C, Norrby-Teglund A, Skrede S, De Waele JJ. Necrotizing skin and soft-tissue infections in the intensive care unit. Clin Microbiol Infect. 2020;26:8–17.

    Article  CAS  PubMed  Google Scholar 

  12. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10–52.

    Article  PubMed  Google Scholar 

  13. Hua C, Bosc R, Sbidian E, De Prost N, Hughes C, Jabre P, et al. Interventions for necrotizing soft tissue infections in adults. Cochrane Database Syst Rev. 2018;5:CD011680.

    PubMed  Google Scholar 

  14. Yilmazlar T, Ozturk E, Alsoy A, Ozguc H. Necrotizing soft tissue infections: APACHE II score, dissemination, and survival. World J Surg. 2007;31:1858–62.

    Article  PubMed  Google Scholar 

  15. Chang CP, Hsiao CT, Lin CN, Fann WC. Risk factors for mortality in the late amputation of necrotizing fasciitis: a retrospective study. World J Emerg Surg. 2018;13:45.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Yeung YK, Ho ST, Yen CH, Ho PC, Tse WL, Lau YK, et al. Factors affecting mortality in Hong Kong patients with upper limb necrotising fasciitis. Hong Kong Med J. 2011;17:96–104.

    CAS  PubMed  Google Scholar 

  17. Martinschek A, Evers B, Lampl L, Gerngroß H, Schmidt R, Sparwasser C. Prognostic aspects, survival rate, and predisposing risk factors in patients with Fournier’s gangrene and necrotizing soft tissue infections: evaluation of clinical outcome of 55 patients. Urol Int. 2012;89:173–9.

    Article  CAS  PubMed  Google Scholar 

  18. Hedetoft M, Madsen MB, Madsen LB, Hyldegaard O. Incidence, comorbidity and mortality in patients with necrotising soft-tissue infections, 2005–2018: a Danish nationwide register-based cohort study. BMJ Open. 2020;10:e041302.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Boyer A, Vargas F, Coste F, Saubusse E, Castaing Y, Gbikpi-Benissan G, et al. Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management. Intensive Care Med. 2009;35:847–53.

    Article  PubMed  Google Scholar 

  20. Hadeed GJ, Smith J, O’Keeffe T, Kulvatunyou N, Wynne JL, Joseph B, et al. Early surgical intervention and its impact on patients presenting with necrotizing soft tissue infections: a single academic center experience. J Emerg Trauma Shock. 2016;9:22–7.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Chao WN, Tsai CF, Chang HR, Chan KS, Su CH, Lee YT, et al. Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis. Am J Surg. 2013;206:32–9.

    Article  PubMed  Google Scholar 

  22. Bruun T, Rath E, Madsen MB, Oppegaard O, Nekludov M, Arnell P, et al. Risk factors and predictors of mortality in streptococcal necrotizing soft-tissue infections: a multicenter prospective study. Clin Infect Dis. 2021;72:293–300.

    Article  CAS  PubMed  Google Scholar 

  23. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of Observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573–7.

    Article  Google Scholar 

  24. Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–82.

    Article  PubMed  Google Scholar 

  25. Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute Physiology and Chronic Health evaluation (APACHE) IV: hospital mortality assessment for today’s critically ill patients. Crit Care Med. 2006;34:1297–310.

    Article  PubMed  Google Scholar 

  26. Attia JR, Oldmeadow C, Holliday EG, Jones MP. Deconfounding confounding part 2: using directed acyclic graphs (DAGs). Med J Aust. 2017;206:480–3.

    Article  PubMed  Google Scholar 

  27. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702–6.

    Article  PubMed  Google Scholar 

  28. Nattino G, Finazzi S, Bertolini G. A new test and graphical tool to assess the goodness of fit of logistic regression models. Stat Med. 2016;35:709–20.

    Article  PubMed  Google Scholar 

  29. DeGenova DT, Hyland SS, Peabody T, Schmitz NP, Myers D, Patterson R, et al. Differences between patients with diabetes mellitus and those without in cases of necrotizing fasciitis. Cureus. 2023;15:e36576.

    PubMed  PubMed Central  Google Scholar 

  30. Ling L, Ho CM, Ng PY, Chan KCK, Shum HP, Chan CY, et al. Characteristics and outcomes of patients admitted to adult intensive care units in Hong Kong: a population retrospective cohort study from 2008 to 2018. J Intensive Care. 2021;9:2.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Zahar JR, Goveia J, Lesprit P, Brun-Buisson C. Severe soft tissue infections of the extremities in patients admitted to an intensive care unit. Clin Microbiol Infect. 2005;11:79–82.

    Article  PubMed  Google Scholar 

  32. van Stigt S, Knubben M, Schrooten T, Tan E. Prognostic factors for mortality in 123 severe cases of necrotizing fasciitis in 5 hospitals in the Netherlands between 2003 and 2017. Eur J Trauma Emerg Surg. 2022;48:1189–95.

    Article  PubMed  Google Scholar 

  33. Oppegaard O, Mylvaganam H, Kittang BR. Beta-haemolytic group A, C and G streptococcal infections in Western Norway: a 15-year retrospective survey. Clin Microbiol Infect. 2015;21:171–8.

    Article  CAS  PubMed  Google Scholar 

  34. DeMuri GP, Sterkel AK, Kubica PA, Duster MN, Reed KD, Wald ER. Macrolide and clindamycin resistance in group a Streptococci isolated from children with pharyngitis. Pediatr Infect Dis J. 2017;36:342–4.

    Article  PubMed  Google Scholar 

  35. Peng XM, Yang P, Liu S, Li J, Zhang DT, Liu YM, et al. [The genetic features of drug resistance to group a streptococcus and macrolides antibiotics among pediatric patients in Beijing 2012]. Zhonghua Yu Fang Yi Xue Za Zhi. 2013;47:1040–4.

    CAS  PubMed  Google Scholar 

  36. Archer EJ, Baker-Austin C, Osborn TJ, Jones NR, Martínez-Urtaza J, Trinanes J, et al. Climate warming and increasing Vibrio vulnificus infections in North America. Sci Rep. 2023;13:3893.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Cheng NC, Wang JT, Chang SC, Tai HC, Tang YB. Necrotizing fasciitis caused by Staphylococcus aureus: the emergence of methicillin-resistant strains. Ann Plast Surg. 2011;67:632–6.

    Article  CAS  PubMed  Google Scholar 

  38. Jabbour G, El-Menyar A, Peralta R, Shaikh N, Abdelrahman H, Mudali IN, et al. Pattern and predictors of mortality in necrotizing fasciitis patients in a single tertiary hospital. World J Emerg Surg. 2016;11:40.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Karnuta J, Featherall J, Lawrenz J, Gordon J, Golubovsky J, Thomas J, et al. What demographic and clinical factors are associated with in-hospital mortality in patients with necrotizing fasciitis? Clin Orthop Relat Res. 2020;478:1770–9.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Ling L, Joynt GM, Lipman J. A narrative review on antimicrobial therapy in septic shock: updates and controversies. Curr Opin Anaesthesiol. 2021;34:92–8.

    Article  CAS  PubMed  Google Scholar 

  41. Asner SA, Desgranges F, Schrijver IT, Calandra T. Impact of the timeliness of antibiotic therapy on the outcome of patients with sepsis and septic shock. J Infect. 2021;82:125–34.

    Article  CAS  PubMed  Google Scholar 

  42. Latifi R, Patel AS, Samson DJ, Tilley EH, Gashi S, Bergamaschi R, et al. The roles of early surgery and comorbid conditions on outcomes of severe necrotizing soft-tissue infections. Eur J Trauma Emerg Surg. 2019;45:919–26.

    Article  PubMed  Google Scholar 

  43. Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (Laboratory Risk Indicator for necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32:1535–41.

    Article  PubMed  Google Scholar 

  44. Tarricone A, Mata K, Gee A, Axman W, Buricea C, Mandato MG, et al. A systematic review and meta-analysis of the effectiveness of LRINEC score for predicting upper and lower extremity necrotizing fasciitis. J Foot Ankle Surg. 2022;61:384–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Beatrix Yu for drawing an illustration of necrotizing fasciitis used in this manuscript. 

Funding

There was no external funding for this study.

Author information

Authors and Affiliations

Authors

Contributions

CHL, LL, JZZ and AL designed the study. LL, PYN, CYC, AWTY, KMF, JKHC, GKFA, TL, MD, FLC, KNL, KMC, SL recruited subjects. CHL, LL, JZZ, and AL collected and analyzed the data. CHL, LL and AL interpreted the data and wrote the first draft of the manuscript. All authors reviewed and approved the final manuscript.

Corresponding author

Correspondence to Anna Lee.

Ethics declarations

Ethics approval and consent to participate

This study was approved by The Joint Chinese University of Hong Kong – New Territories East Cluster Clinical Research Ethics Committee (2020.078), The Hong Kong East Cluster Research Ethics Committee (HKECREC-2020-030), The Institutional Review Board of The University of Hong Kong/Hospital Authority Hong Kong West Cluster (UW20-288), The Research Ethics Committee of Kowloon Central/Kowloon East (KC/KE-20-007/ER-1), The Kowloon West Cluster Research Ethics Committee (KW/EX-20-077(148-01)) and New Territories West Cluster Research Ethics Committee (NTWC/REC/20058). Each individual ethics committee granted waiver of informed consent for this study.

Consent for publication

Not applicable.

Competing interests

All the authors, except the last and corresponding author (AL) declare that they have no competing interests. AL is a content editor for the Cochrane Anaesthesia and Cochrane Emergency and Critical Care Review Groups.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lau, C.H., Ling, L., Zhang, J.Z. et al. Association between time to surgery and hospital mortality in patients with community-acquired limb necrotizing fasciitis: an 11-year multicenter retrospective cohort analysis. BMC Infect Dis 24, 624 (2024). https://doi.org/10.1186/s12879-024-09501-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-024-09501-y

Keywords